您当前所在的位置:首页 > 产品中心 > 产品信息
Lenalidomide_分子结构_CAS_191732-72-6)
点击图片或这里关闭

Lenalidomide

产品号 Bio-0168 公司名称 InterBioScreen
CAS号 191732-72-6 公司网站 http://www.ibscreen.com
分子式 C13H13N3O3 电 话 +7 49652 40091
分子量 259.26062 传 真 +7 49652 40092
纯 度 电子邮件 screen@ibscreen.chg.ru
保 存 Chembase数据库ID: 363

产品价格信息

请登录

产品别名

标题
Lenalidomide
IUPAC标准名
3-(4-amino-1-oxo-2,3-dihydro-1H-isoindol-2-yl)piperidine-2,6-dione
IUPAC传统名
3-(4-amino-1-oxo-2,3-dihydro-1H-isoindol-2-yl)piperidine-2,6-dione
别名
Revimid
Revlimid

产品登记号

CAS号 191732-72-6

产品性质

应用领域 Used against multiple myeloma and myelodysplastic syndromes
生物活性机理 Interfering with the immune system and angiogenesis
生物活性机理 Inhibits the expression of cyclooxygenase-2 (COX-2)

产品详细信息

参考文献

  • Bennett et al. Thalidomide- and lenalidomide-associated thromboembolism among patients with cancer JAMA 2006;296(21):2558-2560
  • List A, Kurtin S, Roe DJ, Buresh A, Mahadevan D, Fuchs D, Rimsza L, Heaton R, Knight R, Zeldis JB. Efficacy of lenalidomide in myelodysplastic syndromes. N Engl J Med 2005;352:549-57. PMID 15703420.
  • Chang DH, Liu N, Klimek V, Hassoun H, Mazumder A, Numer SD, Jagannath S, Dhodapkar MV.
  • Enhancement of ligand dependent activation of human natural killer T cells by lenalidomide: therapeutic implications. Blood 2006;epub ahead of print. PMID 16569772.
  • Anderson KC. Lenalidomide and thalidomide: mechanisms of action--similarities and differences. Semin Hematol 2005;42(4 Suppl 4):S3-8. PMID 16344099.
  • Armoiry, X et al. Lenalidomide in the treatment of multiple myeloma: a review J of Clin Pharmacy & Therapeutics 2008;33:219-226
  • Vellet, S et al Thalidomide and lenalidomide: mechanism-based potential drug combinations Leukemia and Lymphoma 2008;49(7):1238-1245
  • Weber, DM et al. Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America N Engl Med 2007;357(21):2133-2142